Sebela Pharmaceuticals is a U.S. pharmaceutical company focused on gastroenterology and women's health.

Sebela Pharmaceuticals

Domain Not Resolving

Google Maps

CrUX Dataset

CrUX Top 50m

reCAPTCHA v2

Microsoft

CPanel

Verizon

Verizon FIOS

Chief Executive Officer and President

Alan Cooke

Chief Commercial Officer

Scott Briggs

Chief Scientific Officer and Head of R&D

Sue Hall

Vice President - Sales Operations

Adam Roy

Vice President, Trade Relations and Rx Direct

Angie Ulm

Vice President, Commercial Finance & Contracts

David Stocco

Vice President, CMC and Manufacturing Operations, Women's Health R&D

Frank Blondino

VP, Legal Corporate Affairs

Genie Massey

Vice President Clinical Affairs

Kevin Peters

Tsh Aluminium

Founder

President & Chief Executive Officer

Kelly Culwell

Head of Research and Development, Women's Health

Private Greater Atlanta Area Companies (Top 10K)

Georgia Companies With Less Than $500M in Revenue (Top 10K)

Georgia Companies With More Than 10 Employees (Top 10K)

Pharmaceutical Companies with Private Equity Funding

Sebela Pharmaceuticals is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals for patients whose needs are not adequately satisfied. Sebela Pharmaceutical’s commercial activities are focused in the United States for niche therapeutic markets including gastroenterology, dermatology and women’s health.
To fulfill our commitment to improving patient’s lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities.




Private Equity Round - Sebela Pharmaceuticals

Roswell

Georgia

United States

North America

Sebela Pharmaceuticals Announces New Division Named Sebela Women's Health

Sebela Pharmaceuticals® Appoints Victor Parker as Chief Commercial Officer

Sebela Pharmaceuticals Announces FDA Approval of Pizensy™ for oral solution for the Treatment of Chronic Idiopathic Constipation in Adults

A tablet-based bowel preparation product used for colon cleansing prior to a colonoscopy.

An oral solution used for bowel cleansing before a colonoscopy.

An oral solution used for bowel preparation before a colonoscopy.

A hormone-free intrauterine device currently in late-stage Phase 3 trials for contraception.

A hormonal intrauterine device in Phase 3 development for contraception.

South Korea

Asia

Canada

Philippines

India

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 12:08 PM	3675788a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 29, 2024 12:08 PM	d33d1bac
crunchbase trigger	general	Nov 25, 2024 9:06 AM	6172a31f
crunchbase profile	general	Nov 25, 2024 10:47 AM	9727ae95
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 4:18 PM	4aacd05f
peers	general	Sep 29, 2024 12:08 PM	08721bdc
news basic	general	Sep 29, 2024 12:08 PM	1d6b910e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SEBELAPHARMA

Sebela Pharmaceuticals